In Down syndrome, the availability of mature NGF is compromised by diminished tPA/plasminogen → plasmin activity, which limits the production of NGF, further lowered by the increased activity of MMP-9 that degrades NGF [8,9]. The gene discussed is NGF; the disease is Down syndrome.